Skip to main content
    C

    Cadrenal Therapeutics, Inc. Common Stock (CVKD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.88
    +0.48 (+34.29%)

    Market Cap: $4.34M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Cadrenal Therapeutics, Inc. Common Stock (CVKD) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a latest price of $1.88 on Nov 17, 2026, 85.0% below its 52-week high of $12.50. Its price fell 83.8% over the past 12 months. The month-end price fell 85.1% over the 3 years through Oct 2026, a compound annual decline of 47.0%.

    Price Chart

    From Jan 2023 to Oct 2026, its highest month-end close was $41.68 in Jan 2023 and its lowest $0.98 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CVKD with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CVKD.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 14.6%, and over 6 months it fell 62.2%.

    PeriodChange
    1 month+77.4%
    3 months+14.6%
    6 months-62.2%
    12 months-83.8%
    12 months, with dividends-83.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-85.1%-47.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 30.6%, and its weakest was 2025, when it fell 53.2%.

    YearCloseChange
    2026 through Oct 2026$0.98-85.5%
    2025$6.78-53.2%
    2024$14.49+30.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 70.4% above its 50-day average of $1.10 and 47.4% below its 200-day average of $3.58.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.88
    52-week high$12.50-85.0%
    52-week low$0.82+130.4%
    50-day average$1.10+70.4%
    200-day average$3.58-47.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.8%.

    MeasureValue
    1-year beta1.76
    Largest fall, 1 year-92.9%
    Largest fall, 3 years-96.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CVKD

    What is CVKD's 1-year price change?

    Cadrenal Therapeutics, Inc. Common Stock's price fell 83.8% over the past 12 months. With dividends included, the 12-month total return was -83.8%.

    How has CVKD stock done over the long term?

    Cadrenal Therapeutics, Inc. Common Stock's month-end price fell 85.1% over the 3 years through Oct 2026, a compound annual decline of 47.0%. These figures leave out dividends.

    What is CVKD's 52-week high and low?

    Cadrenal Therapeutics, Inc. Common Stock's 52-week high is $12.50 and its 52-week low is $0.82. Its latest price of $1.88 on Nov 17, 2026 is 85.0% below the high.

    What is CVKD's beta?

    Cadrenal Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 1.76, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 92.9%.

    Is the CVKD chart free?

    Yes. Advanced Charting for CVKD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.